LailaBabarMD

Physician

Dr. Babar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4301 S Western Ave
Oklahoma City, OK 73109
Phone+1 405-631-0919

Fax+1 405-636-0518

Allegheny Health Network Medical Education Consortium (AGH)Residency, Internal Medicine, 2017 - 2020
Aga Khan Medical CollegeClass of 2015

PubMed

23 citations
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model.
Ali H. Zaidi, Ronan J. Kelly, Anastasia Gorbunova, Ashten N. Omstead, Madison Salvitti
Oncotarget. 2021-02-16
9 citations
Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma.
Laila Babar, Juliann E. Kosovec, Vida Jahangiri, Nobel Chowdhury, Ping Zheng
Oncotarget. 2019-07-16
5 citations
Retrospective review of total neoadjuvant therapy
Laila Babar, Veli Bakalov, Stephen Abel, Obaid Ashraf, Gene Grant Finley
World Journal of Gastrointestinal Oncology. 2019-10-15

Lectures

Potency of CD8+ T-cell mediated antitumor immunity from intratumoral immunotherapy with STING agonist, ADU-S100, in an esophageal adenocarcinoma model.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
A retrospective analysis of factors affecting palliative care consult in patients undergoing cytoreductive surgery and HIPEC.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
Evaluation of readmission rates for gastrointestinal bleeds in high risk oncologic patients.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019